The signal transducer and activator of transcription (STAT) family proteins are transcription factors critical in mediating cytokine signaling. Among them, STAT3 is frequently activated in a number of human cancers and transformed cell lines and is implicated in tumorigenesis. However, although constitutively activated STAT3 mutant (STAT3C) leads to cellular transformation, its transformation potential such as colony-forming activity in soft-agar is much weaker than that of v-src. To identify tumorigenic factors that cooperatively induce cellular transformation with STAT3C, we screened the retroviral cDNA library. We found that the microphthalmiaassociated transcription factor (MITF), an essential transcription factor for melanocyte development and pigmentation, induces anchorage-independent growth of NIH-3T3 cells in cooperation with STAT3C. Microarray analysis revealed that c-fos is highly expressed in transformants expressing STAT3C and MITF. Promoter analysis and chromatin immunoprecipitation assay suggested that both STAT3 and MITF can cooperatively upregulate the c-fos gene. In addition, the transformation of NIH-3T3 cells by both MITF and STAT3C was significantly suppressed by a dominant-negative AP-1 retrovirus. These data indicate that MITF and STAT3 cooperatively induce c-fos, resulting in cellular transformation.
Introduction
The signal transducer and activator of transcription (STAT) family proteins were identified in the last decade as transcription factors essential for mediating virtually all cytokine signaling (Darnell, 1997; Stark et al., 1998) . These proteins become activated through tyrosine phosphorylation. In addition to their central roles in normal cell signaling, recent studies have demonstrated that constitutively activated STAT signaling, especially STAT3, directly contributes to oncogenesis (Bromberg and Darnell, 2000) . For example, all src-transformed cell lines exhibit constitutively activated STAT3 (Yu et al., 1995) , and dominant-negative STAT3 suppresses src transformation without having any effect on ras transformation (Turkson et al., 1998) . More directly, Bromberg et al. (1999) demonstrated that a constitutively activated form of STAT3, STAT3C, which has two substituted cysteine residues within the C-terminal loop of the SH2 domain, resulting in a spontaneous transcriptionally active dimer, causes cellular transformation scored by colony formation in soft-agar and tumor formation in nude mice. Thus, the activated STAT3 molecule by itself can mediate cellular transformation. Extensive surveys of primary tumors and cell lines derived from tumors have indicated that an inappropriate activation of STAT3 occurs at a surprisingly high frequency in a wide variety of human cancers (Bowman et al., 2000) . However, until now, mutations in the STAT3 gene have not been identified in these cancers, hence it remained to be determined how endogenous STAT3 is constitutively activated and what kinds of genes are involved in tumorigenicity induced by constitutively activated STAT3.
The microphthalmia-associated transcription factor (MITF) is a basic helix-loop-helix leucine zipper (b-HLH-Zip) transcription factor that plays a critical role in the differentiation of various cell types, including neural crest-derived melanocytes, mast cells, osteoclasts, and optic cup-derived retinal pigment epithelium. MITF mutations in humans produce auditory-pigmentary syndromes, such as Waardenburg syndrome type IIa and Tietz syndrome, characterized by mast cell defects, inner ear problems, and abnormal, patchy pigmentation of the hair and skin. In mice, the mi allele protein with the deletion of 216R in the basic region is known as a dominant-negative form through the sequestration of wild-type partners in non-DNA-binding dimmers. In addition to the complete absence of melanocytes, MITF dominant-negative mutants exhibit osteopetrosis (Kitamura et al., 2002) . MITF consists of at least five isoforms, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, and MITF-M is the melanocyte-specific type (Tachibana, 1997; Udono et al., 2000; Shibahara et al., 2001) . MITF regulates the expression of melanocyte differentiation markers, including tyrosinase, tyrosinase-related protein, and dopachrome tautomerase (DCT), all of which are required for pigmentation (Carreira et al., 2000) . MITF is one of the genes involved in tumor growth and the metastasis of melanoma (Vachtenheim et al., 2001, Nyormoi and Bar-Eli, 2003) . However, transcriptional target genes of MITF that regulate melanoma tumorigenicity or metastasis have not yet been elucidated. Moreover, since MITF alone has low or no oncogenic activity, a cofactor(s) that cooperatively functions with MITF may be necessary for the transformation of melanocytes.
In this study, we first demonstrated that STAT3 and MITF cooperatively induce cellular transformation in vitro. We also identified c-fos as a target gene of STAT3 and MITF using microarray analysis. The induction of the c-fos gene is necessary for the anchorage-independent growth of NIH-3T3 cells transformed with STAT3C and MITF. Our study provides a novel role of STAT3 in melanocyte proliferation and tumor growth of melanoma.
Results

Screening for STAT3C cofactors for cellular transformation
We and others have shown that NIH-3T3 cells expressing STAT3C or wild-type STAT3, which is activated by the type C hepatitis virus (HCV) core protein, possess a colony-forming potential in soft-agar and tumorigenicity in nude mice (Yoshida et al., 2002) . However, the number and size of the colonies and tumor size by the expression of active STAT3 are much smaller than those of NIH-3T3 cells transformed with v-src (Bromberg et al., 1999; Yoshida et al., 2002) . Therefore, the constitutive activation of STAT3 may not be sufficient for full transformation. With this in mind, we screened cofactors that induce full transformation in cooperation with activated STAT3 by using retrovirus cDNA transfer (Kitamura et al., 1995) . NIH-3T3 cells expressing STAT3C (STAT3C-3T3) were infected with the HeLa cell retroviral cDNA library (2 Â 10 6 independent clones) and plated into soft-agar medium. After 3 weeks of incubation, two large colonies were formed and the integrated cDNAs were recovered by PCR and sequenced. One colony contained MITF cDNA with Nterminal 104 amino acids deletion compared with MITF-M (DN-MITF), and the other colony included full-length granulin cDNA that has been shown to induce colony formation in soft-agar in NIH-3T3 cells (Zanocco-Marani et al., 1999) . The ATG of the exon 3 of the MITF gene was utilized as the first AUG codon in DN-MITF (Figure 1a) . N-terminal truncation resulted in a missing N-terminal glutamine-rich region, but DN-MITF retained DNA-binding and transactivation domains.
MITF-induced anchorage-independent growth in cooperation with STAT3C
The inserted cDNAs subcloned into the retroviral vector, pMX-IRES-EGFP, were introduced into parental NIH-3T3 cells or STAT3C-3T3 cells and then plated into soft-agar medium. N-terminal-truncated MITF induced the cellular transformation of STAT3C-3T3, but not parental NIH-3T3 cells, whereas granulin cDNA induced anchorage-independent cell growth in both NIH-3T3 cells and STAT3C-3T3 cells (Figure 1b and data not shown). Therefore, DN-MITF has the potential to induce the anchorage-independent growth of NIH-3T3 cells in cooperation with STAT3C. We also found that full-length (wt-) MITF could lead to anchorage-independent growth of NIH-3T3 cells in cooperation with STAT3C ( Figure 1b) . However, DN-MITF showed greater colony-forming activity, both in size and number, than wt-MITF.
We then compared the cellular morphology of transfectants. It has been reported that the forced expression of MITF in NIH-3T3 cells results in refractile cell morphology, which resembled dendritic cells and melanocytes (Tachibana, 1997) . We also observed that DN-MITF-infected NIH-3T3 cells showed dendritic cell-like morphological changes (Figure 2a) . However, as shown in Figure 2b , STAT3C-3T3 cells expressing wt-MITF or DN-MITF displayed some of the morphological changes associated with fibroblast transformation, that is, elongated shape and rounding.
Constitutive activation of STAT3 in melanoma cells
We then examined STAT3 activation in melanoma cells in which MITF plays an important role in transformed Figure 3a , some melanoma cell lines, B16F10, G361, MMAc, and HMV-II, showed constitutive phosphorylation of STAT3. We examined whether MITF induced the constitutive activation of STAT3. Immunoblotting with an anti-phosphorylated STAT3-specific antibody revealed that phosphorylation occurred in tyrosine 705 (Y705) of STAT3 in STAT3C-3T3 cells (Figure 3b ). wt-MITF and DN-MITF did not affect phosphorylation states of STAT3 in NIH-3T3 cells ( Figure 3b ). As shown in Figure 3c , MITF had little effect on or rather suppressed STAT3-dependent APRE-luciferase activity. These data indicate that STAT3 is often constitutively activated in melanoma cells, but the mechanism is probably independent of MITF expression. Furthermore, MITF-transactivation activity was not affected by STAT3C (data not shown). Therefore, we speculated that an oncogenic target gene(s) could be induced by the cooperative action of STAT3 and MITF.
Microarray screening for target genes of STAT3C and MITF
To identify target genes of MITF and STAT3, a microarray-based screen was undertaken. Total RNA was isolated from DN-MITF-infected NIH-3T3 (DN-MITF-3T3), STAT3C-3T3, and DN-MITF-infected STAT3C-3T3 (DN-MITF/STAT3C-3T3) cells and subjected to Affymetrix microarray analysis (about 12000 genes). As summarized in Figure 4a , seven genes in DN-MITF/STAT3C-3T3 cells were identified as more than 10-fold upregulated genes compared with DN-MITF-3T3 and STAT3C-3T3 cells. Most of the genes were mast cell or melanocyte-specific genes and chemokines, and the upregulation of these genes was confirmed by RT-PCR analysis ( Figure 4b ). Among these seven genes, the upregulation of c-fos is particularly interesting because c-fos is a component of the AP-1 transcription factor and known to be an oncogene. The functions of AP-1, composed of Fos family proteins (c-Fos, Fra-1, Fra-2, and FosB) and Jun family proteins (c-Jun, JunB, and JunD), were shown to play important roles not only in normal cell growth but also in several transformed cells induced by oncogenes (Ui et al., 2000) . Therefore, we confirmed the upregulation of the c-fos gene by Northern blotting. As shown in Figure 4c , c-fos was consecutively expressed in DN-MITF/STAT3C-3T3 cells, but was not detected in quiescent 3T3 cells. We also detected the endogenously high expression of c-fos 
STAT3 and MITF directly bind to the promoter region of c-fos
It has been shown that the c-fos proximal promoter region contains a single STAT3-binding site in the SIE region (Shibuya et al., 1994) . We also noticed many MITF-binding motifs (CANNTG; E-box) in the promoter region (Figure 5a ). To confirm that c-fos activation was cooperatively induced by MITF and STAT3C, a reporter gene assay using cfos promoter luciferase constructs (Hatakeyama et al., 1992) was carried out. The transcriptional activity of cfos was significantly increased by the transient expression of wt-or DN-MITF and STAT3C in HEK293 cells. MITF-induced c-fos promoter activation was further stimulated by leukemia inhibitory factor (LIF), which activates endogenous STAT3 (Figure 5b and data not shown). Next, we examined the region of the c-fos promoter responsible for the interaction of MITF and STAT3. The c-fos promoter construct contains five potential MITF-binding sites. Using mutated or truncated forms of the c-fos promoter, we found that the SIE region is important for activation by STAT3 and an MITFbinding motif in the SRE region is essential for promoter activation by MITF (Figure 5c ).
To confirm the direct binding of STAT3 and MITF to the c-fos promoter region, DNA-binding assay ( Figure 5d ) as well as chromatin immunoprecipitation (ChIP) assay ( Figure 5e ) were performed. First, nuclear extracts from 293T cells transfected with Myc-tagged DN-MITF and STAT3C or from cells stimulated with or without LIF were incubated with beads conjugated with oligonucleotides of the human c-fos promoter sequence, including the SIE and the SRE (55 mer). As shown in Figure 5d , MITF (lanes 2, 4, and 6) as well as both phosphorylated endogenous STAT3 (lanes 3 and 4) and STAT3C (lanes 5 and 6) bound to the oligonucleotides of the c-fos promoter region in vitro. Non-phosphorylated STAT3 without LIF stimulation (lanes 1 and 2) did not bind to the oligonucleotide beads, suggesting a specific interaction of activated STAT3 and the DNA.
For ChIP assay (Figure 5e ), the crosslinked chromatins from wt-MITF/STAT3C-3T3 cells and DN-MITF/ STAT3C-3T3 cells as well as melanomas (G361 and HMV-II) in which STAT3 was consecutively phosphorylated were immunoprecipitated with STAT3-or MITF-specific antibodies. The crosslinked protein was then removed from DNA by proteolysis. Finally, the immunoprecipitated DNA was analysed by PCR to detect the c-fos promoter region. As shown in Figure 5e , the anti-STAT3 antibody and the anti-MITF antibody precipitated the c-fos promoter SIE region and the MITF-binding motif in the SRE region, respectively.
Dominant-negative mutant of AP-1 inhibited cellular transformation of MITF/STAT3C-3T3
To investigate the contribution of the c-fos gene in the anchorage-independent growth of MITF/STAT3C-3T3 cells, we introduced a dominant-negative mutant of AP-1 into these cells. We used a retrovirus carrying SupJunD-1, which has an N-terminal deletion of the transactivation domain of c-Jun. We have shown that the SupJunD-1 virus suppresses the transactivation activity of AP-1 and inhibits colony formation in soft agar of various types of tumor cells (Ui et al., 2000) . As shown in Figure 6 , the dominant-negative AP-1 2 mg) , and the wt-MITF plasmid (b, 200 ng, and c, 10 ng). After transfection, cells were incubated in the presence or absence of 10 ng/ml LIF for 8 h, and cell extracts were prepared. Data normalized with the b-galactosidase activity from triplicate experiments are shown. (d) DNA-binding assay. 293T cells were transfected with the pcDNA3-Myc-DN-MITF and pRcCMV-STAT3C and stimulated with 10 ng/ml LIF for 6 h, and the nuclear extracts were prepared. The DNA-binding proteins bound to the oligonucleotide-conjugated beads were analysed by immunoblotting with anti-STAT3 and anti-Myc antibodies. (e) ChIP assay was performed to determine the binding of MITF and STAT3 to the promoter region of c-fos. wt-or DN-MITF-infected STAT3C-3T3 was determined in vitro, and the melanoma cells G361 and HMV-II were examined in vivo. Chromatin complexes were immunoprecipitated with anti-acetylated histone H4, anti-STAT3, and monoclonal or polyclonal anti-MITF antibodies
Discussion
In this study, we identified MITF as a collaborative factor of STAT3 for cellular transformation. Many factors have been shown to interact with and activate (or in some cases inactivate) STAT3. For example, we have shown that the HCV core protein directly interacts with STAT3 and induces phosphorylation and activation (Yoshida et al., 2002) . Nakayama et al. (2002) reported that a nuclear zinc-finger protein EZI enhances the nuclear retention and transactivation of STAT3. PIAS3 (Levy et al., 2002) , cyclinD (Matsui et al., 2002) , and GRIM-19 (Lufei et al., 2003) also interact directly with STAT3, but inhibit transcriptional activity. Most of these factors are isolated as a physical binding protein with STAT3. In this study, by using functional expression screening, we showed that STAT3 and MITF interact functionally, but not physically. A common target of STAT3 and MITF is found to be c-fos, which may participate in transformation by constitutively active STAT3 and MITF. Our functional cloning strategy using retroviral cDNA transfer will provide an additional candidate for the cofactor that modulates the function of STAT3. Furthermore, in this study we demonstrated that the microarray technique is a powerful tool to identify a target gene that is cooperatively induced by two distinct classes of transcription factors.
MITF consists of at least five isoforms, MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, differing at their N-termini and expression patterns (Tachibana, 1997; Udono et al., 2000; Shibahara et al., 2001) . However, the clone (DN-MITF) we obtained from the HeLa cell library has an N-terminal deletion, which is shorter than other reported forms. Since mRNA corresponding to DN-MITF has not been reported, we speculate that DN-MITF is a product of the incomplete elongation of cDNA by reverse transcriptase. Nevertheless, DN-MITF seems to be a more potent inducer for a transformed phenotype of NIH-3T3 cells (Figure 1 ) and c-fos induction (Figure 4) . In addition to the previously characterized acidic activation domain necessary for melanocyte differentiation, a second potential activation domain is shown to be located between amino acids 140 and 185 (Mansky et al., 2002) , and DN-MITF contains these regions. Therefore, the Nterminal, with about 100 amino acids of MITF-M, may be a negative regulatory domain. This region contains a glutamine-rich basic region (QB), but the function of this region has not been elucidated. Most notably, Ser 73 of MITF-M is a predicted MAP kinase-phosphorylation site and is implicated in p300/CBP recruitment (Hemesath et al., 1998) and reduced MITF protein stability (Kim et al., 2003) . Since DN-MITF lacks this Ser 73, dN-MITF may be more stable than wt-MITF.
Several types of functional interactions between STAT3 and MITF have been proposed. The protein inhibitor of activated STAT3 (PIAS3) has been shown to bind to a b-HLH-Zip domain of MITF, resulting in the suppression of MITF-induced transcriptional activity (Levy et al., 2002) . However, it has been reported that STAT3 does not interfere, either in vitro or in vivo, with the interaction between PIAS3 and MITF. This finding is consistent with our data showing that STAT3 does not affect MITF transcriptional activity (data not shown) and MITF does not interfere with STAT3 transcriptional activity (Figure 3c) . Recently, Kamaraju et al. (2002) reported that IL-6 receptor/IL-6 chimera induces a loss of melanogenesis preceded by a sharp decrease in MITF mRNA and gene promoter activity in B16/F10.9 melanoma cells. IL6RIL6 stimulates gp130, leading to the rapid activation of STAT3, which downregulates Pax3, a paired homeodomain factor regulating MITF mRNA levels and the development of melanocytes. Therefore, in this case, MITF downregulation by STAT3 is indirect, and the mechanism of Pax3 downregulation by STAT3 is not clear. The Pax3 downregulation in IL6RIL6-induced F10.9 cells leads to growth arrest and transdifferentiation to a glial cell phenotype. Therefore, the genetic interaction between MITF and STAT3 seems to be complicated and probably different among cell types.
We found that the c-fos gene is a common target of STAT3 and MITF, which probably contributes to transformation. Microarray analysis also revealed that (McGill et al., 2002) . In agreement with this notion, STAT3 was frequently phosphorylated in several human melanoma cell lines (Figure 3a) . However, while B16 and SKMel cells are negative for STAT3 phosphorylation, the same cells do express c-fos. Apparently, STAT3-independent mechanism of c-fos induction is present in these melanoma cells. Finding such mechanisms of c-fos expression in these cells may provide a new clue for understanding the role of c-fos for the generation of melanomas.
Promoter analysis and ChIP assay indicated that STAT3 and MITF can bind to the c-fos promoter and activate this promoter independently. Reporter gene analysis suggested that the effect of MITF and STAT3 on the c-fos promoter are additive rather than cooperative (Figure 5b ). This is consistent with our observation that there is no direct physical interaction between MITF and STAT3. Nevertheless, high levels of c-fos expression and transformation of NIH-3T3 cells are dependent on both STAT3 and MITF. In addition to promoter activation, another mechanism of c-fos expression, such as stabilization of c-fos mRNA, may present in the cooperative effect of STAT3 and MITF. Furthermore, a previous report demonstrated that wtand mi-MITF bind to the c-Fos protein. In particular, mi-MITF prevents c-Fos from being transported to the nucleus, and this may be a reason for the osteopetrosis of mi/mi mutant mice (Sato et al., 1999) . wt-MITF was also shown to bind to c-Jun and enhance the transactivation of the MMCP-7 gene, while complexes of mi-MITF and c-Jun were predominantly found in the cytoplasm and suppressed transactivation (Ogihara et al., 2001) . Thus, MITF could be involved in AP-1 activation not only by inducing c-fos but also by interacting with AP-1 itself. The fact that a dominantnegative AP-1 (SupJunD) suppressed colony formation of transformants expressing both MITF and STAT3C suggests that AP-1 can be a therapeutic target of melanoma.
In addition to c-fos, we found several interesting genes that are cooperatively induced by STAT3 and MITF (Figure 4a ). GTP cyclohydrase-1 and mast cell proteases are probably involved in melanocyte and mast cell functions. PMEL17 is also known as an MITFinducible pigment cell-specific gene and a melanosomal matrix protein, which may function as a structural protein in melanogenesis (Kobayashi et al., 1994) . JE and A7 are chemokines that are induced by immunoglobulin (Ig) E plus antigen stimulation in mast cells. (Burd et al., 1989; Kulmburg et al., 1992; Ong et al., 1993) . Therefore, STAT3/MITF target genes are strongly linked to the function of mast cells and melanocytes, which constitutively express MITF. This finding implies that STAT3 (or other STATs) may be involved in mast cell and melanocyte functions by inducing genes in cooperation with MITF. It is interesting that IL3, which activates STAT5, is a mast cell growth factor in vitro. The functions of STATs in mast cells and melanocytes are under investigation.
Materials and methods
Cell culture and transfection
NIH3T3 and HEK293 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% CS. STAT3C-transformed 3T3 (STAT3C-3T3) cells (Yoshida et al., 2002) were cultured in DMEM supplemented with 10% CS containing 0.8 mg/ml G418. PLAT-E, a packaging cell line (Morita et al., 2000) was maintained in DMEM with 10% FCS containing blasticidin S (10 mg/ml) and puromycin (1 mg/ml). Melanoma cell lines were cultured in the following medium containing 10% FCS, B16 and B16F10 in RPMI 1640, G361 and SKMel28 in MEM, HMV-II in Ham's F12, and MMAc in DMEM. MC9, a mast cell line, was cultured in RPMI 1640 supplemented with 5% FCS, 50 mM 2-mercaptoethanol, and 6 ng/ml mouse recombinant IL-3. Cells were transfected by the calcium phosphate method with Cell Phect (Amersham) or by the lipofection method with FuGENE 6 (Roche). For retrovirus-mediated gene expression, NIH3T3 cells were infected with the retroviruses produced by PLAT-E as reported (Sasaki et al., 2003) . B16, B16F10, G361, and SKMel 28 cell lines were kindly provided by Dr Yonemitsu (Kyushu University, Japan).
Library screening
Retroviruses containing the human HeLa retroviral cDNA library (CLONTECH, Palo Alto, CA, USA) were produced from PLAT-E and 1 Â 10 6 STAT3C-3T3 cells were infected with 10 ml of the retroviral supernatant containing 10 mg/ml polybrene. After 48 h of virus transduction, STAT3C-3T3 cells were seeded in soft-agar medium. Within 3 weeks, two colonies were picked up and expanded, and genomic DNA was isolated. Integrated cDNAs were recovered by PCR using a pair of primers (FWD, 5 0 -AGCCCTCACTCCTTCTCTAG, and REV, 5 0 -ATGGCGTTACTTAAGCTAGCTTGC-CAAACCTAC) and sequenced.
Colony formation in soft-agar
The MITF-infected 3T3 and STAT3C-3T3 cells were seeded into 35-mm dishes in suspensions of 0.36% Agar noble (Difco) in DMEM supplemented with 10% CS on top of a bed of 0.72% Agar noble in the same complete medium. The MITFinfected STAT3C-3T3 cells were inoculated with a retrovirus of dominant-negative AP-1 or an empty vector (Ui et al., 2000) , selected with puromycin, and plated into soft-agar medium. The cultures were incubated for 21 days and then the colonies were counted and photographed.
Construction of MITF
The cDNAs of wt-, DN-, and mi-MITF were subcloned into a bicistronic retrovirus vector pMX-IRES-EGFP (Nosaka et al., 1999) or a pcDNA3 expression vector.
Retrovirus of dominant-negative AP-1
The control virus (pBabe-IRESpuro) and the SupJunD-1 virus (pBabe-SupJunD-1-IRESpuro) as a dominant-negative AP-1 were generated as described (Ui et al., 2000) . After infection, STAT3C-3T3 cells were cultured with 2 mg/ml puromycin.
High-density oligonucleotide microarray analysis
RNA was extracted by standard methods. Cells were lysed directly in their Petri dishes in TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and total RNA was isolated according to 
Western blotting analysis
Cells were lysed in a lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5% or 1% NP-40, 1 mM EDTA, 1 mM vanadate, 50 mM NaF, 1 mM DTT, 0.01 mM APMSF) and centrifuged at 12 000 g for 10 min. The supernatants were resolved on SDS-PAGE of 10% gels, blotted, and immunostained with an anti-phospho STAT3 (Tyr705) polyclonal antibody (Cell Signaling Technology) and an anti-STAT3 polyclonal antibody (Santa Cruz Biotechnology).
Luciferase assay
An APRE-luciferase reporter gene for STAT3 activity and a reporter gene construct containing MITF-responsive mMCP-6 (mouse mast cell protease) luciferase have been described previously Yasukawa et al., 1999) . A c-fos promoter-reporter gene consisting of the c-fos promoter region containing SIE, SRE, and several potential MITFbinding motifs is also described (Shibuya et al., 1994; Kawahara et al., 1995; Kim et al., 1998) . Luciferase assays were carried out using the dual-luciferase reporter system (Promega). The expression plasmid of STAT3-C in pRcCMV was kindly provided by Dr JE Darnell Jr (Bromberg et al., 1999) .
Nuclear extract preparation and oligonucleotide-binding assay 293T cells (1.5 Â 10 7 ) were transfected with Myc-DN-MITF and STAT3C were stimulate with LIF for 6 h. Cells were collected and resuspended in 0.4 ml of buffer A (10 mM HEPES-KOH (pH 7.8), 10 mM KCl, 0.1 mM EDTA, 0.4% NP-40, 1 mM DTT, 0.5 mM APMSF, 2 mg/ml leupeptin, and 1 mM Na 3 VO 4 ). After a brief vortexing and centrifugation, the supernatant was discarded and the nuclei-containing pellet was resuspended in 0.05 ml of buffer C (50 mM HEPES-KOH (pH 7.8), 420 mM NaCl, 5 mM MgCl 2 , 0.1 mM EDTA, 2% glycerol, 1 mM DTT, 0.5 mM APMSF, 2 mg/ml leupeptin, and 1 mM Na 3 VO 4 ) at 41C for 30 min. The suspension was pelleted by centrifugation and the supernatants were collected and stored at À801C until use. Oligonucleotide-conjugated beads were prepared using the DNA-binding protein purification kit (Roche) according to the manufacturer's protocol. In brief, the sense and antisense oligonucleotide of the human c-fos promoter sequence, including the SIE and SRE regions (5 0 -C AGTTCCCGTCAATCCCTCCCCCCTTACACAGGATGTC CATATTAGGACATCTGC-3 0 ) were annealed, and they were ligated with the washed streptavidin magnetic particles for 30 min at 251C. After ligation was carried out, the particles were washed using a magnetic separator and mixed with 100 mg of the nuclear extract for 30 min at 251C. Then, the particles were washed and the DNA-binding proteins were eluted. The elutates were pelleted with trichloroacetic acid solution, and analysed by immunoblotting with anti-STAT3 and anti-Myc antibodies.
ChIP assay
For ChIP assay, 243T cells (5 Â 10 6 ) were fixed with 1% formaldehyde for 10 min at 371C, washed with PBS, and lysed in ChIP lysis buffer (Upstate Biotechnology, Lake Placid, NY, USA). DNA was sonicated by pulsing five times. Antiacetylated histone H4 (Upstate), anti-STAT3 (Sigma), or anti-MITF monoclonal antibody (Oncogene), and anti-MITF polyclonal antibody (Santa Cruz Biotechnology) was added (5 mg-20 mg per immunoprecipitation) and incubated overnight. Protein A-agarose beads (Upstate Biotechnology) were added for 1 h and then washed once each with a low-salt buffer, high-salt buffer, and LiCl buffer. They were then washed twice with a TE buffer. The beads were eluted with 0.1 M NaHCO3 and 1% SDS, and crosslinks were reversed at 651C. DNA was ethanol precipitated in the presence of 20 mg glycogen. PCR was carried out using primers specific to the promoter region of mouse c-fos (FWD, 5 0 -TCTGCCTTTCCCGCCTCCCC, and REV, 5 0 -GGCCGTGGAAACCTGCTGAC) for NIH3T3, and human c-fos (FWD, 5 0 -CCCGACCTCGGGAACAAGGG, and REV, 5 0 -ATGAGGGGTTTCGGGGATGG) for HMV-II, or (FWD, 5 0 -TCTCATTCTGCGCCGTTCCC, and REV, 5 0 -GGCCGTGGAAACCTGCTGAC) for G361.
